At-home STI test pulled from Australian shelves after failing to detect infections
Australia's Therapeutic Goods Administration has suspended the only approved at-home STI test kit for chlamydia and gonorrhoea due to reliability concerns. The manufacturer, Touch Biotechnology, has ceased supply while further verification testing is conducted.
Why it matters
The suspension creates a significant gap in public health access for STI screening and raises concerns about the accuracy of self-testing medical devices.
Australia’s only approved at-home test kit for gonorrhoea and chlamydia has been suspended by the TGA. Australia’s only approved at-home test kit for gonorrhoea and chlamydia has been suspended by the TGA. Health At-home STI test pulled from Australian shelves after failing to detect infections Exclusive: TGA finds Touch Biotechnology test for chlamydia and gonorrhoea ‘is not reliable’ and has affected an unspecified number of people
Get our breaking news email , free app or daily news podcast
Prefer the Guardian on Google Australia’s only approved home test for chlamydia and gonorrhoea has been pulled from shelves after it failed to detect infections for an unspecified number of patients.
Touch Biotechnology has been handed a six‑month suspension by the Therapeutic Goods Administration (TGA) after a review of the company’s self‑testing kit found “the device is not reliable … and poses a high risk for false negative results for users”.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in